Viability of Customized, Marked Syringes for Gentamicin Delivery for the Outpatient Treatment of Neonatal Sepsis

In light of the World Health Organization's guidelines for outpatient treatment of neonatal sepsis when referral is not feasible, this brief provides an analysis of relevant technical, regulatory, manufacturing, procurement, logistical, and training considerations of a customized, marked syringe for delivery of gentamicin.

Publication date: October 2016

Viability of Customized, Marked Syringes for Gentamicin Delivery for the Outpatient Treatment of Neonatal Sepsis

530.9 KB PDF

Hard copies are not available.

View Resource